Sustained caloric restriction potentiates insulin action by activating prostacyclin synthase
Obesity · 2024
DOI: 10.1002/oby.24150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, 2024. Verfasst von Carmen Merali und 6 weiteren Autor:innen. Beteiligte Einrichtung: Temple University School of Pharmacy, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Caloric Restriction, Insulin, Insulin Resistance, Cytochrome P-450 Enzyme System. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIA NIH HHS, NIDDK NIH HHS, NIH HHS.
Abstract (Originalsprache)
Objective
Caloric restriction (CR) is known to enhance insulin sensitivity and reduce the risk of metabolic disorders; however, its molecular mechanisms are not fully understood. This study aims to elucidate specific proteins and pathways responsible for these benefits.
Methods
We examined adipose tissue from participants in the Comprehensive Assessment of Long‐term Effects of Reducing Intake of Energy Phase 2 (CALERIE 2) study, comparing proteomic profiles from individuals after 12 and 24 months of CR with baseline and an ad libitum group. Biochemical and cell‐specific physiological approaches complemented these analyses.
Results
Our data revealed that CR upregulates prostacyclin synthase (PTGIS) in adipose tissue, an enzyme crucial for producing prostacyclin (PGI2). PGI2 improves the ability of insulin to stimulate the tether‐containing UBX domain for GLUT4 (TUG) cleavage pathway, which is essential for glucose uptake regulation. Additionally, iloprost, a PGI2 analog, was shown to increase insulin receptor density on cell membranes, increasing glucose uptake in human adipocytes. CR also reduces carbonylation of GLUT4, a modification that is detrimental to GLUT4 function.
Conclusions
CR enhances insulin sensitivity by promoting PTGIS expression and stimulating the TUG cleavage pathway, leading to increased GLUT4 translocation to the cell surface and decreased GLUT4 carbonylation. These findings shed light on the complex molecular mechanisms through which CR favorably impacts insulin sensitivity and metabolic health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Temple University School of Pharmacy, Philadelphia, Pennsylvania, USA.
- Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina, USA.
- Duke Molecular Physiology Institute, Duke University School of Medicine, Durham, North Carolina, USA.
- Duke Center for Aging and Human Development, Duke University School of Medicine, Durham, North Carolina, USA.
- Section of Endocrinology and Metabolism, Department of Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
- Department of Cell Biology, Yale School of Medicine, New Haven, Connecticut, USA.
ORCID-Profile: Jonathan S Bogan, Salim Merali
Förderung
- NIA NIH HHS
- NIDDK NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Merali, C., Quinn, C., Huffman, K. M., Pieper, C. F., Bogan, J. S., Barrero, C. A., & Merali, S. (2024). Sustained caloric restriction potentiates insulin action by activating prostacyclin synthase. Obesity. https://doi.org/10.1002/oby.24150
Vancouver
Merali C, Quinn C, Huffman KM, Pieper CF, Bogan JS, Barrero CA, et al. Sustained caloric restriction potentiates insulin action by activating prostacyclin synthase. Obesity. 2024. doi:10.1002/oby.24150
BibTeX
@article{Merali2024,
author = {Merali, Carmen and Quinn, Connor and Huffman, Kim M and Pieper, Carl F and Bogan, Jonathan S and Barrero, Carlos A and Merali, Salim},
title = {Sustained caloric restriction potentiates insulin action by activating prostacyclin synthase},
journal = {Obesity},
year = {2024},
doi = {10.1002/oby.24150}
}
EUVIMED